Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for OSUR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 317.78M
March 31, 2026 313.32M
December 31, 2025 340.83M
September 30, 2025 361.98M
June 30, 2025 380.72M
March 31, 2025 396.28M
December 31, 2024 410.34M
September 30, 2024 425.56M
June 30, 2024 425.84M
March 31, 2024 426.25M
December 31, 2023 430.67M
September 30, 2023 404.88M
June 30, 2023 394.14M
March 31, 2023 394.18M
December 31, 2022 364.42M
September 30, 2022 341.89M
June 30, 2022 344.19M
March 31, 2022 364.89M
December 31, 2021 380.53M
September 30, 2021 387.82M
June 30, 2021 404.82M
March 31, 2021 403.54M
December 31, 2020 398.57M
September 30, 2020 387.89M
June 30, 2020 381.76M
Date Value
March 31, 2020 290.15M
December 31, 2019 307.14M
September 30, 2019 301.36M
June 30, 2019 288.22M
March 31, 2019 280.51M
December 31, 2018 283.38M
September 30, 2018 276.75M
June 30, 2018 265.17M
March 31, 2018 258.72M
December 31, 2017 258.08M
September 30, 2017 249.51M
June 30, 2017 229.41M
March 31, 2017 208.82M
December 31, 2016 185.85M
September 30, 2016 176.48M
June 30, 2016 168.79M
March 31, 2016 163.02M
December 31, 2015 159.44M
September 30, 2015 160.00M
June 30, 2015 159.85M
March 31, 2015 155.83M
December 31, 2014 158.70M
September 30, 2014 160.92M
June 30, 2014 160.32M
March 31, 2014 154.71M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M
Alphatec Holdings, Inc. 11.53M
AtriCure, Inc. 516.43M
Baxter International, Inc. 6.206B

Shareholders Equity (Quarterly) Related Metrics